📊 Backtest📒 Journal Updated 29/09/2026
← 🔥 Turbo
📐 Simulate Position
STALE?Report written 7 days ago · at $3.47entry levels may be stale — re-check before acting

NB

ค่าขนมSMALL CAP
NioCorp Developments Ltd. · NASDAQ · Materials / Critical Minerals
$3.47
▲ 0.00%
MCap $506M
Self-fetched today (live-prices.json cache dated Aug 13, too stale to use). Down 27.9% since the last report ($4.81 → $3.47) despite two genuinely positive milestones — the 2026 Feasibility Study (Aug 10) and a Lockheed Martin scandium MOU (Aug 4) — both of which the stock actually sold off on (-1.65% and -3.28% same-day). The decline tracks a broader rare-earth sector pullback around the Trump-Xi summit rather than a company-specific break.
BusinessCritical minerals · Elk Creek niobium/scandium/titanium project — 2nd-largest indicated US rare-earth resource · 2026 Feasibility Study complete ($4.1B pre-tax NPV8%) · $800M EXIM Bank debt financing still in review
Thesis

NioCorp's Elk Creek project cleared a real EXIM Bank requirement this quarter: the Aug 10 2026 Feasibility Study ($4.1B pre-tax NPV8%, 2.93-year after-tax payback, 40-year mine life across 8 minerals) lets the company move toward detailed engineering and EPC contracting, though EXIM's financing amount and timing 'remain uncertain' per the company's own language — still no confirmed decision date. Jefferies initiated coverage Sep 2 at Hold, $4.70 (+35% from here) — the low end of a 6-analyst Buy consensus averaging $11.12 (+220%). The stock has fallen 28% since July anyway, including selling off on both pieces of good news, which reads as sector-wide rare-earth cooling (Trump-Xi summit eased trade-war urgency around critical minerals) rather than a NB-specific thesis break. Genuinely wider entry now, but the binary EXIM catalyst is still undated and dilution risk from a pre-revenue, multi-billion-dollar capex build remains real.

📝 Primary Verdict · Core Holding
SPECULATIVEค่าขนม

ค่าขนม SPECULATIVE — 2% max, smallest sizing on the board given the undated catalyst. Measured turbo median at-catalyst return is -13.7% (n=19, entryGuidance.turbo), so buy the dip zone ($2.95-3.25), not the current price. Base (EXIM review advances) → $5.03 (+45%), Bull (positive EXIM signals) → $7.98 (+130%), Moon (EXIM $800M finalized) → $11.10 (+220%).

81
score / 100 ⓘ
⚡ Catalyst
🏦 EXIM Bank $800M Debt Financing DecisionIN REVIEW

The Aug 10 2026 Feasibility Study satisfies a key EXIM Bank technical requirement, unlocking progress toward detailed engineering and EPC contracting. The company itself says the eventual EXIM financing amount and timing remain uncertain — still no confirmed Board decision date.

H2 2026
🛡️ Lockheed Martin Scandium MOUSIGNED (NON-BINDING)

Non-binding agreement (Aug 4) for Lockheed to purchase up to 15 tonnes/year of scandium oxide over a decade, building on NioCorp's existing $10M DPA Title III Pentagon award. A real defense-industrial offtake signal, even though the stock sold off -3.28% the day it was announced.

Aug 4, 2026
🇺🇸 Project Vault — $12B Critical Minerals StockpilePOLICY TAILWIND (COOLING)

Trump's Project Vault ($10B EXIM facility + ~$2B private capital) remains the policy tailwind NB's EXIM application sits inside. The Sep 2026 Trump-Xi summit easing trade tensions has cooled sector urgency somewhat — a real risk to the policy-tailwind half of this thesis, not just noise.

2026
🎯 Entry Point
Entry 1
$3.47
Current price — down 28% since July despite good news; measured turbo median at-catalyst return is -13.7% (n=19), so this is not the default entryNow (2% max)
Entry 2PREFERRED
$2.95–3.25
Below the recent offering price zone — better entry given the demonstrated pattern of selling into good newsIf dips
Entry 3
$2.20
Deep dip zone — high conviction add onlyDeep dip
✅ Take Profit
TP1
Base — EXIM review keeps advancing without a final decision; Base assumes a ~6-9mo horizon as engineering/EPC work continues, driven by re-rating toward the Jefferies floor target
$5.03
+45%
TP2
Bull — EXIM review reaches late-stage/positive signals, matches mid-Street consensus range
$7.98
+130%
TP3 🌙
Moon — EXIM finalizes the $800M debt commitment, fully de-risking construction financing; hits the 6-analyst consensus average
$11.1
+220%
🔴 Stop Loss
Tight Stop
Wider than the turbo regulatory_approval-type median MAE (-25%, n=8) since this name has shown it sells off on good news — a tighter stop would get shaken out by noise
$2.5
-28%
Hard Stop
EXIM financing rejected/delayed indefinitely or a new dilutive down-round raise — thesis materially impaired
$1.56
-55%
Risk / Reward
Entry ($3.47) vs TP2 ($7.98), tight stop ($2.50)
4.6 : 1
⚠ Good asymmetry ✅ — but dilution risk is ongoing, not one-time, and this is a multi-month not multi-week story
📅 Estimate Date
EXIM Bank Financing Decision
Feasibility Study (Aug 10) clears a technical requirement; Board decision timeline still undisclosed
H2 2026 (no confirmed date)
Process advancing, timeline not disclosed
📈 Possible Up % — Scenario Spread
Bear
-55%
$1.56
Base
+45%
$5.03
Bull
+130%
$7.98
Moon
+220%
$11.1
← downsideupside →
🏛️ Fed / Macro Risk — MEDIUM

Assesses how Fed policy / interest rates / inflation affect this stock — LOW = minimal risk, HIGH = proceed with caution

Rate Outlook
As a pre-revenue project-finance story, NB is genuinely rate-sensitive — the EXIM debt package's cost and NioCorp's equity-raise capacity both get harder in a higher-for-longer rate environment.
Inflation
Construction and equipment costs for the newly-scoped 8-mineral Elk Creek build are exposed to input-cost inflation; a hot CPI print raises project capex risk directly.
Sector Impact
MEDIUM-HIGH. The added wrinkle since the last report: the Trump-Xi summit shows the critical-minerals policy tailwind itself is not immune to macro/geopolitical shifts — this is now a two-sided macro exposure (rates AND trade-policy sentiment), not just a rates story.
Summary
Fed risk MEDIUM — this remains the one pick on the board where the macro/policy backdrop hits the catalyst directly (EXIM cost/availability, Project Vault urgency), not just the trading multiple.
🎯 Analyst Targets

Wall Street price targets vs the current price — cross-check our TP levels

Consensus (6 analysts, S&P Global)
Buy$11.12+220%
Jefferies (Sep 2, most conservative)
Hold$4.7+35%
current price $3.47
🔍 Similar-Catalyst Comparable Check

Stocks that went through similar catalyst events — calibrate whether the +30%+ target is realistic

NB❌ BadAug 10, 2026
-1.65%
in 1 day
2026 Feasibility Study release ($4.1B pre-tax NPV8%, clears key EXIM requirement)
Same-company precedent for the current pattern: genuinely positive project-finance progress, sold on the news anyway. Confirms this is a sector-sentiment issue, not a company-execution one.
NB❌ BadAug 4, 2026
-3.28%
in 1 day
Lockheed Martin scandium oxide MOU (defense offtake signal)
Second same-company data point in one week showing real news isn't moving the stock — reinforces that a company-specific EXIM finalization will need to be large enough to break through current sector skepticism.
CRML✅ GoodFeb 2026
+35%
in 1 day
Project Vault $12B Critical Minerals Stockpile Announcement
Shows the sector CAN move sharply on policy catalysts — the question is whether NB's own EXIM news can still trigger this now that the Trump-Xi summit has cooled the policy tailwind somewhat.
⚡ Optional Layer · Tactical Overlay
🎯 Catalyst Spot Mode

Short-term play around the catalyst (Sep 2026 earnings) only — an optional overlay, not a verdict that ranks equal to the Core Holding.

⚠️

Use this stop-loss set (-28% / -55%) only when trading the earnings spot — not for the core holding (use the -28% / -55% set above). If you are holding long-term, follow the core set.

📈Pre-Catalyst Run-up Pattern
+10-35% historically (sector), but NB itself has recently moved the opposite way on good newsdays ก่อน policy headline (unpredictable timing) — though NB's own recent reactions have broken this pattern

Critical-minerals small-caps have historically run hard on Trump administration policy headlines (Project Vault, tariff/export-control news, DPA awards) even without a company-specific announcement — but NB itself has NOT shown this pattern this quarter, selling off on its own good news instead.

🎲Historical Post-Catalyst Move
✅ Catalyst Winavg +20%
range: +4% to +35%· Feb-Apr 2026 (sector); Aug 2026 (NB's own muted/negative reactions)
Sector precedent: CRML surged 35% on the Feb 2026 Project Vault announcement, USAR rose ~13% on its Serra Verde acquisition (Apr 2026). NB's own recent reactions (Feasibility Study -1.65%, Lockheed MOU -3.28%) have NOT matched this pattern — a genuine EXIM finalization would need to overcome the current sector-wide skepticism, not just be good news on its own.
❌ Catalyst Missavg -40%
range: -25% to -55%· Hypothetical — no direct comp found; NB's own -28% drift since July shows the downside is already partly playing out absent an actual rejection
A rejected or indefinitely delayed EXIM application would force NioCorp toward more dilutive equity financing, likely triggering a sharp de-rate given how central the $800M debt package is to the bull case; per turbo.overall stopGuidance, drawdowns of this type median around -25% for regulatory_approval catalysts (n=8) but can run deeper on financing-specific breaks.
💼Spot Position Sizing
How the recommended % is derived
2%
of portfolio

2% — smallest sizing on this list. NB's EXIM decision has no confirmed timeline, carries real dilution risk, AND has now shown it sells off on its own good news — three compounding reasons to size minimally.

🛑Stop Loss · Spot Trade
Spot cut-loss levels — separate from the core holding
Before Catalyst
-28%($2.5)
หลุด $2.50 = financing sentiment แย่ลงต่อเนื่อง แม้ EXIM ยังไม่ตัดสิน — กว้างกว่า median MAE ของกลุ่ม regulatory_approval (-25%, n=8) เพราะหุ้นตัวนี้ขายลงแม้ข่าวดี
After Catalyst (Bad Result)-55%
ถ้า EXIM ปฏิเสธหรือ delay ไม่มีกำหนด หรือมี down-round raise ใหม่ — exit
📎 Sources

Generated 2026-09-29 · Not financial advice